A Single-arm, Multicenter Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Electromechancial Autoinjector to Self-inject Etanercept
Phase of Trial: Phase III
Latest Information Update: 10 Sep 2018
Price : $35 *
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriatic arthritis; Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Amgen
- 21 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 26 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 29 Jul 2013 New trial record